Oligodendrocyte progenitor cells (OPCs) actively contribute to neuroinflammation associated with multiple sclerosis.
Removing Piezo1 from the surface of aged brain stem cells caused the cells to become rejuvenated and regain their normal regenerative function.
Researchers have identified a molecule in white matter that prevents the brain from repairing itself following injury. By blocking the production of the molecule, researchers say it may allow an effective pathway for neuroregeneration.
A new study in Scientific Reports concludes human herpesvirus 6 may impair the brain's ability to repair itself in demylination diseases, such as multiple sclerosis. HHV-6 is the most common human herpes virus, with an estimated 80% of people being exposed to infection during childhood. Researchers found the virus produces a protein that can impair the ability of brain cells to repair damaged myelin.
A new study reports Sirt1 can help glial cells to regenerate from progenitor cells in preterm babies with hypoxia related injuries.
A new study reports two over the counter medications could activate neural stem cells to stimulate myelin producing cells and may offer new treatment options for multiple sclerosis.
A new study reports transplanted human stem cells treated with FDA approved drug boost myelin synthesis.
Researchers are looking at different processes which go awry in MS.
